NasdaqGM - Delayed Quote USD
TransMedics Group, Inc. (TMDX)
At close: October 25 at 4:00 PM EDT
After hours: October 25 at 7:58 PM EDT
Research Analysis
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 10 | 10 | 10 | 10 |
| Avg. Estimate | 0.29 | 0.28 | 1.26 | 1.91 |
| Low Estimate | 0.03 | -0.23 | 0.49 | 0.59 |
| High Estimate | 0.39 | 0.49 | 1.57 | 3.45 |
| Year Ago EPS | -0.78 | 0.12 | -0.77 | 1.26 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 9 | 9 | 10 | 10 |
| Avg. Estimate | 115M | 119.37M | 444.36M | 582.74M |
| Low Estimate | 111M | 116M | 438M | 525M |
| High Estimate | 118.6M | 124.7M | 453.5M | 635.05M |
| Year Ago Sales | 66.43M | 81.17M | 241.62M | 444.36M |
| Sales Growth (year/est) | 73.10% | 47.10% | 83.90% | 31.10% |
Earnings History
| CURRENCY IN USD | 9/30/2023 | 12/31/2023 | 3/31/2024 | 6/30/2024 |
|---|---|---|---|---|
| EPS Est. | -0.16 | -0.06 | -0.04 | 0.21 |
| EPS Actual | -0.78 | 0.12 | 0.35 | 0.35 |
| Difference | -0.62 | 0.18 | 0.39 | 0.14 |
| Surprise % | -387.50% | 300.00% | 975.00% | 66.70% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0.29 | 0.28 | 1.26 | 1.91 |
| 7 Days Ago | 0.29 | 0.28 | 1.26 | 1.91 |
| 30 Days Ago | 0.29 | 0.28 | 1.26 | 1.92 |
| 60 Days Ago | 0.29 | 0.29 | 1.26 | 1.85 |
| 90 Days Ago | 0.15 | 0.09 | 0.8 | 1.12 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | TMDX | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 137.20% | -- | -- | 4.50% |
| Next Qtr. | 133.30% | -- | -- | 9.60% |
| Current Year | 263.60% | -- | -- | 2.10% |
| Next Year | 51.60% | -- | -- | 12.90% |
| Next 5 Years (per annum) | -- | -- | -- | 11.76% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Upgrades & Downgrades
| Maintains | Piper Sandler: Overweight to Overweight | 10/7/2024 |
| Initiated | Baird: Outperform | 9/24/2024 |
| Reiterates | Needham: Buy to Buy | 8/23/2024 |
| Initiated | Needham: Buy | 8/21/2024 |
| Maintains | Stephens & Co.: Overweight to Overweight | 8/2/2024 |
| Maintains | Piper Sandler: Overweight to Overweight | 8/1/2024 |
Related Tickers
DXCM DexCom, Inc.
73.44
-1.88%
PRCT PROCEPT BioRobotics Corporation
68.77
+2.90%
CLPT ClearPoint Neuro, Inc.
13.04
+3.66%
BSX Boston Scientific Corporation
84.73
-0.43%
EW Edwards Lifesciences Corporation
69.38
-1.38%
NXL Nexalin Technology, Inc.
2.2900
+6.51%
INMD InMode Ltd.
17.55
-0.85%
IRTC iRhythm Technologies, Inc.
75.68
-3.12%
ECOR electroCore, Inc.
11.38
+10.06%
SYK Stryker Corporation
352.82
-1.97%